Takashi Akiba Selected Research

ferric citrate

1/2019	Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study.
3/2018	Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide.
7/2014	Long-term safety and efficacy of a novel iron-containing phosphate binder, JTT-751, in patients receiving hemodialysis.
5/2014	A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis.
3/2014	Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD.
1/2014	JTT-751 for treatment of patients with hyperphosphatemia on peritoneal dialysis.
1/2012	Effect of oral JTT-751 (ferric citrate) on hyperphosphatemia in hemodialysis patients: results of a randomized, double-blind, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Akiba Research Topics

Disease

19	Chronic Renal Insufficiency 01/2019 - 09/2008
15	Secondary Hyperparathyroidism 01/2021 - 09/2004
15	Anemia 03/2018 - 07/2003
15	Chronic Kidney Failure (Chronic Renal Failure) 12/2010 - 07/2002
13	Infections 01/2019 - 10/2000
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 08/2004
8	Kidney Diseases (Kidney Disease) 11/2018 - 09/2004
8	Vascular Calcification 10/2017 - 08/2003
7	Hyperphosphatemia 07/2014 - 06/2004
6	Hypertension (High Blood Pressure) 04/2014 - 01/2004
4	Fistula 05/2008 - 11/2002
3	Inflammation (Inflammations) 03/2018 - 01/2002
3	Weight Gain 11/2017 - 03/2007
3	Atrial Fibrillation 12/2016 - 04/2007
3	Stroke (Strokes) 12/2016 - 06/2010
3	Hypotension (Low Blood Pressure) 07/2014 - 07/2002
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2014 - 11/2011
3	Heart Failure 03/2013 - 04/2006
3	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 10/2011 - 05/2004
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2011 - 08/2004
3	Renal Insufficiency (Renal Failure) 06/2010 - 08/2004
3	Hemorrhage 01/2007 - 01/2003
2	Drug-Related Side Effects and Adverse Reactions 01/2021 - 03/2014
2	Vomiting 10/2017 - 01/2017
2	Hyperuricemia 10/2015 - 09/2014
2	Hypercalcemia (Milk Alkali Syndrome) 06/2015 - 12/2004
2	Pruritus (Itching) 07/2014 - 12/2004
2	Ischemia 03/2013 - 12/2005
2	Coronary Artery Disease (Coronary Atherosclerosis) 03/2013 - 04/2006
2	Arteriovenous Fistula 01/2013 - 05/2008
2	Hepatitis C 08/2012 - 06/2004
2	Peripheral Arterial Disease 04/2012 - 10/2006
2	Liver Diseases (Liver Disease) 01/2011 - 10/2000
2	Amyloidosis 05/2009 - 01/2008
2	Metabolic Bone Diseases (Osteopenia) 04/2009 - 05/2004
2	Peritonitis 12/2007 - 01/2003
2	Peritoneal Fibrosis 12/2007 - 01/2003
2	Body Weight (Weight, Body) 06/2007 - 01/2003
2	Hyperparathyroidism 05/2007 - 03/2003
2	Glomerulonephritis 04/2007 - 01/2007
2	Osteoporosis 01/2007 - 12/2004
2	Bone Diseases (Bone Disease) 03/2005 - 05/2004
2	Iron Deficiencies 01/2005 - 07/2003
2	Orthostatic Hypotension (Postural Hypotension) 07/2002 - 04/2002
2	Dizziness (Lightheadedness) 07/2002 - 04/2002
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2018
1	Nausea 10/2017

Drug/Important Bio-Agent (IBA)

12	IronIBA 01/2019 - 07/2003
11	Hemoglobins (Hemoglobin)IBA 11/2018 - 07/2003
10	CalciumIBA 01/2021 - 06/2004
10	Erythropoietin FDA Link 12/2016 - 01/2002
7	Parathyroid Hormone (Parathormone)IBA 01/2021 - 03/2003
7	Phosphates (Orthophosphate)IBA 01/2019 - 08/2007
7	ferric citrateIBA 01/2019 - 01/2012
7	Phosphorus (Red Phosphorus)IBA 11/2018 - 06/2004
6	etelcalcetide hydrochlorideIBA 01/2021 - 01/2017
6	Serum AlbuminIBA 11/2017 - 10/2004
4	Alkaline PhosphataseIBA 01/2021 - 01/2007
4	HematinicsIBA 01/2015 - 06/2010
4	Proteins (Proteins, Gene)FDA Link 10/2012 - 09/2004
4	MineralsIBA 10/2011 - 11/2004
4	AntigensIBA 01/2011 - 09/2004
4	Biomarkers (Surrogate Marker)IBA 01/2007 - 08/2003
3	Dialysis SolutionsIBA 08/2020 - 04/2007
3	Ferritins (Ferritin)IBA 02/2017 - 07/2003
3	Transferrin (beta 2 Transferrin)IBA 02/2017 - 07/2003
3	C-Reactive ProteinIBA 10/2015 - 01/2007
3	Sevelamer (RenaGel)FDA Link 05/2014 - 01/2008
3	CreatinineIBA 04/2014 - 12/2004
3	Cinacalcet (Sensipar)FDA Link 02/2013 - 04/2008
3	Vitamin D FDA LinkGeneric 05/2007 - 09/2004
2	Calcium-Sensing ReceptorsIBA 07/2017 - 01/2017
2	LDL Lipoproteins (beta Lipoproteins)IBA 10/2015 - 01/2005
2	oxidized low density lipoproteinIBA 10/2015 - 01/2005
2	Allopurinol (Remid)FDA LinkGeneric 10/2015 - 09/2014
2	Calcitriol (Calcijex)FDA LinkGeneric 06/2015 - 03/2003
2	maxacalcitolIBA 06/2015 - 12/2004
2	SBR 759IBA 02/2014 - 11/2011
2	iodofiltic acidIBA 03/2013 - 12/2008
2	Darbepoetin alfa (Aranesp)FDA Link 12/2012 - 02/2010
2	PotassiumIBA 11/2012 - 03/2007
2	OsteocalcinIBA 10/2011 - 01/2007
2	Collagen Type I (Type I Collagen)IBA 10/2011 - 01/2007
2	SteroidsIBA 01/2011 - 01/2007
2	Bicarbonates (Hydrogen Carbonate)IBA 04/2007 - 10/2004
2	CytokinesIBA 11/2005 - 07/2002
2	hydroxide ionIBA 12/2004 - 07/2002
2	OsteoprotegerinIBA 07/2004 - 08/2003
1	Therapeutic UsesIBA 08/2020
1	Biological ProductsIBA 03/2018

Therapy/Procedure

64	Renal Dialysis (Hemodialysis) 01/2021 - 10/2000
19	Therapeutics 04/2018 - 05/2004
5	Continuous Ambulatory Peritoneal Dialysis (CAPD) 10/2017 - 07/2002
4	Peritoneal Dialysis 01/2014 - 01/2003
4	Kidney Transplantation 01/2011 - 05/2004
4	Catheters 10/2008 - 01/2003
3	Blood Transfusion (Blood Transfusions) 06/2010 - 04/2006
2	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2014 - 08/2004
2	Blood Component Removal (Apheresis) 01/2009 - 01/2005
2	Plasma Exchange 01/2007 - 01/2005